BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32586113)

  • 1. Sodium valproate prescription to women of childbearing age in a New Zealand inpatient psychiatric unit.
    Goldspink R; Pumipi T; Dey S; Menkes DB
    Australas Psychiatry; 2020 Oct; 28(5):555-558. PubMed ID: 32586113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A UK clinical audit addressing the quality of prescribing of sodium valproate for bipolar disorder in women of childbearing age.
    Paton C; Cookson J; Ferrier IN; Bhatti S; Fagan E; Barnes TRE
    BMJ Open; 2018 Apr; 8(4):e020450. PubMed ID: 29654033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief intervention reduces prescription of sodium valproate in women of childbearing age.
    Goldspink R; Pumipi T; Menkes DB
    Australas Psychiatry; 2023 Aug; 31(4):524-527. PubMed ID: 37035997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Conceivably Neglected' - Are prescribers sufficiently aware of the risks of prescribing sodium valproate to women with mental illness?
    Perera C; Patterson S; Bruxner G
    Australas Psychiatry; 2019 Apr; 27(2):125-128. PubMed ID: 30763123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate prescription to women of childbearing age in English primary care: repeated cross-sectional analyses and retrospective cohort study.
    Gaudio M; Konstantara E; Joy M; van Vlymen J; de Lusignan S
    BMC Pregnancy Childbirth; 2022 Jan; 22(1):73. PubMed ID: 35086478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach?
    Macfarlane A; Greenhalgh T
    BMC Pregnancy Childbirth; 2018 Jun; 18(1):200. PubMed ID: 29859057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of valproate in women of childbearing potential: pre- and post-NICE bipolar guidelines.
    Vasudev K; Mead A
    Arch Womens Ment Health; 2010 Aug; 13(4):371-2. PubMed ID: 20440523
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prescribing valproate to girls and women of childbearing age in Germany : Analysis of trends based on claims data].
    Wentzell N; Haug U; Schink T; Engel S; Liebentraut J; Linder R; Onken M; Schaefer C; Dathe K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Aug; 61(8):1022-1029. PubMed ID: 29922910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproate in acute mania: is our practice evidence based?
    Vasudev K; Mead A; Macritchie K; Young AH
    Int J Health Care Qual Assur; 2012; 25(1):41-52. PubMed ID: 22455007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproate prescription prevalence among women of childbearing age.
    Wisner KL; Leckman-Westin E; Finnerty M; Essock SM
    Psychiatr Serv; 2011 Feb; 62(2):218-20. PubMed ID: 21285103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should women of childbearing potential be prescribed valproate? a call to action.
    Balon R; Riba M
    J Clin Psychiatry; 2016 Apr; 77(4):525-6. PubMed ID: 27137420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive recommendations on the use of valproic acid in pregnant or gestational women to be very present.
    García-Portilla MP; Bobes J
    Rev Psiquiatr Salud Ment; 2017; 10(3):129-133. PubMed ID: 28688547
    [No Abstract]   [Full Text] [Related]  

  • 13. Informing patients of the teratogenic potential of mood stabilizing drugs: a case note review of the practice of psychiatrists.
    James L; Barnes TR; Lelliott P; Taylor D; Paton C
    J Psychopharmacol; 2007 Nov; 21(8):815-9. PubMed ID: 17881432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic Acid in Women and Girls of Childbearing Age.
    Gotlib D; Ramaswamy R; Kurlander JE; DeRiggi A; Riba M
    Curr Psychiatry Rep; 2017 Sep; 19(9):58. PubMed ID: 28726062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription of sodium valproate to women of childbearing potential in Southern District Mental Health Services in New Zealand.
    Corfe-Tan J; McLay L; Mentzel C
    Australas Psychiatry; 2023 Dec; 31(6):776-781. PubMed ID: 37632171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in sodium valproate dispensing in women of childbearing age with a diagnosis of borderline personality disorder in Aotearoa New Zealand.
    Tennant M; Frampton C; Mulder R; Eggleston K; Beaglehole B
    N Z Med J; 2024 Jun; 137(1597):36-43. PubMed ID: 38901047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of valproate in psychiatric practice.
    Haddad PM; Das A; Ashfaq M; Wieck A
    Expert Opin Drug Metab Toxicol; 2009 May; 5(5):539-51. PubMed ID: 19409030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium valproate and the fetus: a case study and review of the literature.
    Smith J; Whitehall J
    Neonatal Netw; 2009; 28(6):363-7. PubMed ID: 19892633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Perinatal Women Attending a Mother and Baby Unit Taking Sodium Valproate or Lithium with a Diagnosis of Bipolar Affective Disorder.
    Lebedevs T; Gan M; Teoh SWK; Brown P
    Psychiatr Q; 2020 Sep; 91(3):695-701. PubMed ID: 32157548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium valproate induced acute pancreatitis in a bipolar disorder patient: a case report.
    Huang W; Ren X; Shen F; Xing B
    BMC Pharmacol Toxicol; 2019 Nov; 20(1):71. PubMed ID: 31783774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.